Mei Sheng Duh

Comparative effectiveness of pegcetacoplan versus ravulizumab in patients with paroxysmal nocturnal hemoglobinuria previously treated with eculizumab: a matching-adjusted indirect comparison.

Bhak RH, Mody-Patel N, Baver SB, Kunzweiler C, Yee CW, Sundaresan S, Swartz N, Duh MS, Krishnan S, Sarda SP.

Curr Med Res Opin. 2021 Sep 03. 1-11. PMID: 34445916

Symptom control in patients with asthma using inhaled corticosteroids/long-acting ß2-agonists (fluticasone furoate/vilanterol or budesonide/formoterol) in the US: a retrospective matched cohort study.

Averell CM, Laliberté F, Germain G, Duh MS, Lima R, Mahendran M, Slade DJ.

J Asthma. 2021 Aug 25. 1-14. PMID: 34375568

Disease and Economic Burden Associated with Recurrent Pericarditis in a Privately Insured United States Population.

Lin D, Laliberté F, Majeski C, Magestro M, Lejeune D, Duh MS, Lim-Watson M, Paolini JF.

Adv Ther. 2021 Oct. 38(10):5127-5143. PMID: 34417724

Trifluridine/Tipiracil and Regorafenib in Patients with Metastatic Colorectal Cancer: A Retrospective Study at a Tertiary Oncology Center.

Patel AK, Abhyankar R, Brais LK, Duh MS, Barghout VE, Huynh L, Yenikomshian MA, Ng K, Fuchs CS.

Oncologist. 2021 Aug 18. PMID: 34406678

Disease burden and treatment adherence among children and adolescent patients with asthma.

Averell CM, Laliberté F, Germain G, Slade DJ, Duh MS, Spahn J.

J Asthma. 2021 Aug 04. 1-10. PMID: 34346263

Time-to-first exacerbation, adherence, and medical costs among US patients receiving umeclidinium/vilanterol or tiotropium as initial maintenance therapy for chronic obstructive pulmonary disease: a retrospective cohort study.

Slade D, Ray R, Moretz C, Germain G, Laliberté F, Shen Q, Duh MS, Mahendran M, Hahn B.

BMC Pulm Med. 2021 Jul 31. 21(1):253. PMID: 34332555

Real-World Treatment Patterns and Overall Survival of Patients with Metastatic Castration-Resistant Prostate Cancer in the US Prior to PARP Inhibitors.

Shore ND, Laliberté F, Ionescu-Ittu R, Yang L, Mahendran M, Lejeune D, Yu LH, Burgents J, Duh MS, Ghate SR.

Adv Ther. 2021 08. 38(8):4520-4540. PMID: 34282527

Real-World Healthcare Resource Utilization (HRU) and Costs of Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) Receiving Eculizumab in a US Population.

Cheng WY, Sarda SP, Mody-Patel N, Krishnan S, Yenikomshian M, Mahendran M, Lejeune D, Yu LH, Duh MS.

Adv Ther. 2021 08. 38(8):4461-4479. PMID: 34275086

Clinical Outcomes Among Patients With Metastatic Pancreatic Ductal Adenocarcinoma Treated With Liposomal Irinotecan.

Yu KH, Hendifar AE, Alese OB, Draper A, Abdelrahim M, Burns E, Khan G, Cockrum P, Bhak RH, Nguyen C, DerSarkissian M, Duh MS, Bahary N.

Front Oncol. 2021. 11:678070. PMID: 34336666

Beyond Frontline Therapy with Abiraterone and Enzalutamide in Metastatic Castration-Resistant Prostate Cancer: A Real-World US Study.

Shore ND, Ionescu-Ittu R, Laliberté F, Yang L, Lejeune D, Yu L, Duh MS, Mahendran M, Kim J, Ghate SR.

Clin Genitourin Cancer. 2021 Jul 10. PMID: 34373223